Orbital atherectomy: Device evolution and clinical data

Journal of Invasive Cardiology

Volumn 26, Issue 5, 2014, Pages 215-219

  Staniloae, Cezar S ^a   Korabathina, Ravikiran ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Bayfront Cardiovascular Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCURY; STAINLESS STEEL;

ARTICLE; ATHERECTOMY; BIOMEDICAL ENGINEERING; CLINICAL STUDY; DEVICE SAFETY; EVOLUTION; HISTORY; HUMAN; MULTICENTER STUDY (TOPIC); ORBITAL ATHERECTOMY; ORBITAL ATHERECTOMY DEVICE; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADVERSE EFFECTS; DEVICES; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; STENT; TRENDS;

ANGIOPLASTY, BALLOON; ATHERECTOMY; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; HUMANS; PLAQUE, ATHEROSCLEROTIC; STENTS;

EID: 84899821804     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation.J Endovasc Ther.2001;8(5):477-483
2. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropop-liteal artery obstructions: A multicenter prospective randomized study.J Vasc Interv Radiol.2001;12(1):23-31
3. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.N Engl J Med.2006;354(18):1879-1888
4. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month re-sults from the RESILIENT randomized trial. Circ Cardiovasc Interv.2010;3(3):267-276
5. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation.2007;116(18):2072-2085
6. Mohler ER 3rd, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation.2001;103(11):1522-1528
7. Bostrom K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions.J Clin Invest.1993;91(4):1800-1809
8. Moussa I, Di Mario C, Colombo A. Plaque removal prior to stent implantation in native coronary arteries: Why?. When?. And how?. Semin Interv Cardiol.1998;3(2):57-63
9. Makam P. Use of orbital atherectomy treatment in a high-volume clinical practice modifies non-compliant plaque to deliver durable long-Term results.J Invasive Cardiol.2013;25(2):85-88
10. Zeller T, Sievert H, Frank U, et al. TCT 40: Initial clinical experience with the orbital ather-ectomy system. Am J Cardiol.2005;96:19H.
11. .Scheinert D, Sievert H, Maleux G, et al. TCT-612: Final results of a european study of orbital atherectomy: A new technology for treating occlusive peripheral arterial disease. Am J Cardiol.2008;102:230i.
12. .Safian RD, Niazi K, Runyon JP, et al. Orbital atherectomy for infrapopliteal disease: Device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv.2009;73(3):406-412
13. Korabathina R, Mody KP, Yu J, et al. Orbital atherectomy for symptomatic lower extremity disease. Catheter Cardiovasc Interv.2010;76(3):326-332
14. Das T, Mustapha J, Indes J, et al. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: The CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv.2014;83(1):115-122.Epub 2013 Oct 7
15. Staniloae CS, Korabathina R, Lane TA, et al. Study to determine the clinical significance of HEmolysis During Orbital AtheRectomy (CLEAR study).J Endovasc Ther.2011;18(1):57-63
16. Adams GL, Khanna PK, Staniloae CS, et al. Optimal techniques with the Diamondback 360 degrees system achieve effective results for the treatment of peripheral arterial disease.J Cardiovasc Transl Res.2011;4(2):220-229
17. Shammas NW, Lam R, Mustapha J, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: Results of the CALCIUM 360 randomized pilot trial.J Endovasc Ther.2012;19(4):480-488
18. Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360 trial: A randomized, prospec-Tive, multicenter, pilot study comparing acute and long-Term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease.J Invasive Cardiol.2014 (in press).
19. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting.J Am Coll Cardiol.2005;45(2): 312-315
20. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.N Engl J Med.2008;358(7):689- 699
21. .Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal ar-Teries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation.2008;118(13):1358-1365.